Genetic Variants in DENND1A May Affect Reproductive, Metabolic Profiles in PCOS
Researchers identified rare genetic variants in the DENND1A gene that may contribute to the distinctive hormonal traits of polycystic ovary syndrome.
Women’s Health
Multiple Measurements of AMH Levels Do Not Improve Prediction of Menopause
Multiple measurements of anti-müllerian hormone over time do not improve the prediction of age at menopause.
Metformin May Reduce Risk for Preterm Births, Miscarriage in PCOS
In pregnant women with polycystic ovary syndrome (PCOS), metformin treatment from the late first trimester until delivery might reduce the risk for late miscarriage and preterm birth but does not prevent gestational diabetes.
Prenatal Testosterone Exposure Reduces Socioeconomic Success, Fertility of Female Co-Twins
Women exposed to a male co-twin in utero have decreased probability of fertility and socioeconomic success, according to study findings published in PNAS. For this study, researchers constructed a multivariable linear regression model to study the long-term effects of testosterone transfer in females who are opposite-sex co-twins. The model was designed using a longitudinal data…
Underreporting of Study Cohort Sex Distribution Common in Biomedical Research
A large-scale bibliometric analysis underscores a lack of sex-related reporting in biomedical research, despite efforts to include more women in health-based studies.
New Title X Rule Threatens Contraceptive Access for American Women
A new rule by the Trump administration may make it more challenging for women to access contraceptive services, despite evidence of the benefits to women, families, and the nation as a whole.
Genetic Variant May Put Some Women at Increased Risk for Contraception Failure
A genetic variant may play a major role in why hormonal contraception fails in some women, according to a new study published in Obstetrics & Gynecology.
Menstruation and Migraine: Can We End the Cycle?
Researchers found that lower levels of estrogen during menstruation cause women to be more vulnerable to migraines than men.
Novel Combined Oral Contraceptive Effective in Phase 3 Trial
Previous Phase 2 studies confirmed esterol has minimal impact on liver cells and metabolic pathways, as well as on coagulation parameters.
Impact of Women’s Health Initiative on Menopausal Hormone Therapy Trends
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
Next post in Androgen and Reproductive Disorders
